» Articles » PMID: 28637512

Single- or Double-unit UCBT Following RIC in Adults with AL: a Report from Eurocord, the ALWP and the CTIWP of the EBMT

Overview
Journal J Hematol Oncol
Publisher Biomed Central
Specialties Hematology
Oncology
Date 2017 Jun 23
PMID 28637512
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The feasibility of cord blood transplantation (CBT) in adults is limited by the relatively low number of hematopoietic stem/progenitor cells contained in one single CB unit. The infusion of two CB units from different partially HLA-matched donors (double CBT) is frequently performed in patients who lack a sufficiently rich single CB unit.

Methods: We compared CBT outcomes in patients given single or double CBT following reduced-intensity conditioning (RIC) in a retrospective multicenter registry-based study. Inclusion criteria included adult (≥18 years) patients, acute myeloid leukemia (AML) or acute lymphoblastic leukemia (ALL), complete remission (CR) at the time of transplantation, first single (with a cryopreserved TNC ≥ 2.5 × 10/kg) or double CBT between 2004 and 2014, and RIC conditioning.

Results: Data from 534 patients with AML (n = 408) or ALL (n = 126) receiving a first single (n = 172) or double (n = 362) CBT were included in the analyses. In univariate analysis, in comparison to patients transplanted with a single CB, double CB recipients had a similar incidence of neutrophil engraftment but a suggestion for a higher incidence of grade II-IV acute GVHD (36 versus 28%, P = 0.08). In multivariate analyses, in comparison to single CBT recipients, double CBT patients had a comparable incidence of relapse (HR = 0.9, P = 0.5) and of nonrelapse mortality (HR = 0.8, P = 0.3), as well as comparable overall (HR = 0.8, P = 0.17), leukemia-free (HR = 0.8, P = 0.2) and GVHD-free, relapse-free (HR = 1.0, P = 0.3) survival.

Conclusions: These data failed to demonstrate better transplantation outcomes in adult patients receiving double CBT in comparison to those receiving single CBT with adequate TNC after RIC.

Citing Articles

Outcomes of graft failure after umbilical cord blood transplantation in acute leukemia: a study from Eurocord and the Acute Leukemia Working Party of the EBMT.

Baron F, Ruggeri A, Peczynski C, Labopin M, Bourhis J, Michallet M Bone Marrow Transplant. 2023; 58(8):936-941.

PMID: 37165084 DOI: 10.1038/s41409-023-02000-9.


Impact of allele-level HLA matching on outcomes after double cord blood transplantation in adults with malignancies.

Fatobene G, Mariano L, Volt F, Moreira F, Conelissen J, Furst S Blood Adv. 2023; 7(13):3297-3306.

PMID: 36877784 PMC: 10336258. DOI: 10.1182/bloodadvances.2022009251.


Comparison of HLA-mismatched unrelated donor transplantation with post-transplant cyclophosphamide versus HLA-haploidentical transplantation in patients with active acute myeloid leukemia.

Baron F, Labopin M, Tischer J, Ciceri F, Raiola A, Blaise D Bone Marrow Transplant. 2022; 57(11):1657-1663.

PMID: 35978005 DOI: 10.1038/s41409-022-01781-9.


Umbilical cord blood transplantation: Still growing and improving.

Zhu X, Tang B, Sun Z Stem Cells Transl Med. 2021; 10 Suppl 2:S62-S74.

PMID: 34724722 PMC: 8560197. DOI: 10.1002/sctm.20-0495.


Better leukemia-free survival with allogeneic than with autologous HCT in AML patients with isolated trisomy 8: a study from the ALWP of the EBMT.

Baron F, Labopin M, Blaise D, Itala-Remes M, Socie G, Forcade E Bone Marrow Transplant. 2020; 56(2):461-469.

PMID: 32887941 DOI: 10.1038/s41409-020-01051-6.


References
1.
Lewis S, Clarke M . Forest plots: trying to see the wood and the trees. BMJ. 2001; 322(7300):1479-80. PMC: 1120528. DOI: 10.1136/bmj.322.7300.1479. View

2.
Wagner J, Barker J, DeFor T, Baker K, Blazar B, Eide C . Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood. 2002; 100(5):1611-8. DOI: 10.1182/blood-2002-01-0294. View

3.
Barker J, Weisdorf D, DeFor T, Blazar B, Miller J, Wagner J . Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood. 2003; 102(5):1915-9. DOI: 10.1182/blood-2002-11-3337. View

4.
Barker J, Weisdorf D, DeFor T, Blazar B, McGlave P, Miller J . Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood. 2004; 105(3):1343-7. DOI: 10.1182/blood-2004-07-2717. View

5.
Baron F, Storb R . Hematopoietic cell transplantation after reduced-intensity conditioning for older adults with acute myeloid leukemia in complete remission. Curr Opin Hematol. 2007; 14(2):145-51. DOI: 10.1097/MOH.0b013e3280168462. View